Fondo · Feb 2026
Third-party launch coverage describing Artos’s regulatory-submissions product, founders, and workflow for turning source data into high-quality first drafts faster.
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
San Francisco-based, YC Winter 2024 life-sciences AI startup building a source-traceable document authoring and management platform for regulatory writing; public evidence points to a small, hybrid team and no public layoffs, shutdowns, or acquisitions in the reviewed sources.
Primary product
AI-powered document creation and management platform for life sciences regulatory writing
Founded
2023
Headquarters
San Francisco, California, United States
Team size
1-10 employees
Work style
Hybrid
Industry
Biotechnology Research
Sub-industry
Life sciences document authoring software
Offices
0 jobs at Artos
Check back later for new openings
Business model
Stage
pre-seed
Total raised
$500K
Latest round
Pre-Seed · Mar 2024
Latest amount
$500K
Mar 2024 · Y Combinator
Leadership
Co-Founder and CEO
Co-Founder and CTO
Head of Product
Head of Data Science, Founding Engineer
Investors
Reliability- and trust-oriented startup culture with a fast-paced, intense cadence; public job postings emphasize in-person collaboration in Mission Bay 4-5 days/week, human-in-the-loop review, transparency, and workflow fit for regulated life-sciences teams.
Work style
Hybrid
Visa sponsorship
Limited
Compensation
Public job postings show fully hybrid San Francisco roles with equity and salary bands around $130.5K-$242K; the Founding Account Executive role is listed at $340K-$440K OTE plus equity and commission.
Benefits
Pricing
Subscription-based SaaS with annual tiers and scalable enterprise pricing
Differentiators
Technology
Customers
Competitors
Estimated revenue
Approximately $770K annually (estimated)
Estimated monthly visits
4.7K
Fondo · Feb 2026
Third-party launch coverage describing Artos’s regulatory-submissions product, founders, and workflow for turning source data into high-quality first drafts faster.
Artos AI · Jan 2026
Official recap/announcement for JPM 2026 highlighting growing adoption across life sciences teams, deeper enterprise engagement, and the company’s focus on building practical regulated-workflow software.
Artos AI · Nov 2025
Conference recap focused on why the hard part is not first drafts but review, iteration, and fitting AI into real medical-writing workflows.
Artos AI · Oct 2025
Josh Kim’s session on reliability in regulatory writing and how Artos is building trustable AI for regulated document workflows.
Artos AI Blog · May 2025
Product/engineering essay explaining Artos’s agentic modular architecture, emphasizing transparency, scalability, maintainability, and eliminating brittle prompt libraries.